InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 AS... (r 2011 as follows: R& Webcast...)

HOME >> MEDICINE >> TECHNOLOGY

InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study

Date:5/25/2011

r 2011 as follows:

R&D expense: anticipated to be in a range of approximately $85 to $95 million.
SG&A expense: anticipated to be in a range of approximately $65 to $75 million.

Webcast Information – May 26, 8:30 a.m. EDT

To access the webcast of the Analyst Day presentations, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About Pirfenidone

Pirfenidone is an orally active, small molecule drug that inhibits the synthesis of TGF-beta, a chemical mediator that controls many cell functions including proliferation and differentiation, and plays a key role in fibrosis. It also inhibits the synthesis of TNF-alpha, a cytokine that is known to have an active role in inflammation.

On February 28, 2011, the European Commission (EC) granted marketing authorization for Esbriet^® (pirfenidone) for the treatment of adults with mild to moderate IPF. The approval authorizes marketing of Esbriet in all 27 EU member states. Esbriet has since been approved for marketing in Norway and Iceland.

Since 2008, pirfenidone has been marketed in Japan as Pirespa^® by Shionogi & Co. Ltd. Pirfenidone is still under investigation for the treatment of IPF in the United States and has not been approved by the U.S. Food and Drug Administration for this use. InterMune currently plans to conduct ASCEND, a new Phase 3 study, toward the goal of bringing pirfenidone to IPF patients in the United States, and currently expects to enroll the first patient in ASCEND in June 2011.

About IPF

Idiopathic pulmona
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
2. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
3. InterMune to Present at J.P. Morgan Healthcare Conference
4. InterMune Reports Third Quarter 2010 Financial Results
5. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
6. InterMune to Release Second Quarter Financial Results on July 27
7. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
8. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
9. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
10. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
11. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010

Post Your Comments:

(Date:5/22/2013)... YORK , May 22, 2013 ... investigating potential claims on behalf of purchasers of ... the "Company") (NasdaqGS: AMAG -News). The investigation focuses ... federal securities laws. On May 22, ... during intraday trading after the company announced in ...

(Date:5/22/2013)... WHITE PLAINS, N.Y. , May 22, 2013 /PRNewswire/ ... $6 million to Valor Biotherapeutics, LLC, a ... completion of pre-clinical development, manufacturing, and a Phase I ... change the poor outcomes faced by many patients with ... with rituximab. Valor,s protein, IGN002, is ...

(Date:5/22/2013)... NEW YORK , May 22, 2013 The ... international conference devoted to advancing new treatments for lupus ... to 60 percent of patients. The conference launched a ... – the Lupus Nephritis Trials Network (LNTN). ... lupus and the kidney came together to focus on ...

Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4 Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis 2

[0] Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.[0] The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients [0] Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis

... N.J., Sept. 29 Sparta Systems, Inc. ... software and the market leader in enterprise ... Qualitest Pharmaceuticals , a top-six provider of ... streamline multiple quality and compliance processes. ...

... China, Sept. 29 /PRNewswire-Asia-FirstCall/ -- ... ... var ... by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...

Qualitest Pharmaceuticals Selects TrackWise® for Comprehensive Enterprise Quality and Document Management Shengtai Pharmaceutical Reports Financial Results for Full Year Fiscal 2010

(Date:5/22/2013)... Researchers in genomic health disparities from the University ... University School of Medicine have teamed up to hold ... Eliminate Health Disparities in Genomic Medicine." The theme ... nonprofits, business and government to reduce these disparities. , ... United States, individuals within underserved groups continue to be ...

(Date:5/22/2013)... By Maureen Salamon HealthDay Reporter , , WEDNESDAY, ... each cause a great deal of suffering, but new ... linked to something else entirely -- a smaller brain. ... double the risk of depression, scientists wanted to determine ... The difference in size -- about 2 percent -- ...

(Date:5/22/2013)... 22, 2013 Award Presented at the ... press release here: http://bit.ly/13DkFfk , Merrill Corporation ... “Information Management Product/Service of the Year” at the 7th ... The Colony Hotel in Palm Beach, Florida. , ... room (VDR) solution that optimizes the due diligence ...

(Date:5/22/2013)... May 22, 2013 Recent tragedies ... and the school shooting in Newtown, Connecticut all ... , Emergency medical practitioners train to ... the Emergency Medical Services for Children (EMSC) Program ... care for the youngest patients. It is estimated ...

(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science ... sharing a recipe for making energy bars at home. , ... ,” takes a recipe modified from one recently featured ... day it gets more and more difficult to understand what ... size of the nutrition label continues to grow and consumers ...

Breaking Medicine News(10 mins):Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2 Health News:Having Both Migraines, Depression May Mean Smaller Brain 2 Health News:Having Both Migraines, Depression May Mean Smaller Brain 3 Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2 Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3 Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2 Health News:How To "Make Your Own Healthy Energy Bars" 2

[0] Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine [0] Having Both Migraines, Depression May Mean Smaller Brain [0] Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year”[0] When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care [0] How To "Make Your Own Healthy Energy Bars"

... FRIDAY, Oct. 1 (HealthDay News) -- A good night,s ... levels normal, new research suggests. Pregnant women who got ... had systolic blood pressure readings in their last trimester that ... hours nightly, the study found. And women who got less ...

... 1, 2010 A UC Irvine infectious disease specialist has ... of new methods to prevent staph infections in people who ... The federal Agency for Healthcare Research & Quality awarded Huang ... funded by American Recovery & Reinvestment Act of 2009. CHOICE ...

... (Oct.. 1, 2010)"It,s Your Game: Keep It Real," an evidence-based ... Texas Health Science Center at Houston (UTHealth), will be implemented ... part of a federally-funded program to tackle the U.S. teenage ... Human Services (HHS) awarded $15 million of its $155-million total ...

... a University of California, Berkeley, researcher could give women a ... study suggests that women who get dental care reduce their ... at least one-third. The analysis, which used data ... and Retirement Study, did not find a similar benefit for ...

... , THURSDAY, Sept. 30 (HealthDay News) -- New research finds ... soon as levels of a biomarker for the cancer rise ... begin to reappear. Blood levels of the marker, known ... ovarian cancer relapse, but there has been some debate on ...

... of the journal Sleep found that getting too little ... blood pressure in the third trimester. The study suggests that ... show that the mean systolic blood pressure in the third trimester ... sleep duration of nine hours in early pregnancy, 118.05 mm Hg ...

Cached Medicine News:Health News:Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure 2 Health News:Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure 3 Health News:UCI gets major funding to study ways of preventing drug-resistant staph infections 2 Health News:UTHealth researchers awarded $15 million for teen pregnancy prevention 2 Health News:Women who get dental care have lower risk of heart disease, says study 2 Health News:Women who get dental care have lower risk of heart disease, says study 3 Health News:New Clues to Treating Ovarian Cancer Relapse 2 Health News:New Clues to Treating Ovarian Cancer Relapse 3 Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 2 Health News:Short and long sleep in early pregnancy linked to high blood pressure in the third trimester 3

Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure UCI gets major funding to study ways of preventing drug-resistant staph infections UTHealth researchers awarded $15 million for teen pregnancy prevention Women who get dental care have lower risk of heart disease, says study New Clues to Treating Ovarian Cancer Relapse Short and long sleep in early pregnancy linked to high blood pressure in the third trimester

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

Medicine Products:

Doxepin, Urine Drinox, Serum Dramamine, Urine Doxycycline, Antimicrobial (Serum or Body Fluid) Level, BA